Mediastinal Kaposiform Hemangioendothelioma and Kasabach-Merritt Phenomenon in a Patient with no Skin Changes and a Normal Chest CT

被引:7
|
作者
Wallenstein, Matthew B. [1 ]
Hole, Michael K. [1 ]
McCarthy, Chad [1 ]
Fijalkowski, Natalia [1 ]
Jeng, Michael [1 ]
Wong, Wendy B. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA
关键词
CT; dermatologic findings; hemangioma; kaposiform hemangioendothelioma; Kasabach-Merritt phenomenon; pericardial effusion; skin changes; HEMANGIOMAS; CHILDHOOD;
D O I
10.3109/08880018.2013.825356
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 16-month-old previously healthy boy was admitted to the hospital with respiratory distress and thrombocytopenia. Initial workup demonstrated large pleural and pericardial effusions. The patient had no cutaneous abnormality on physical examination, and his initial chest CT (computed tomography) was nondiagnostic. He required multiple platelet transfusions, chest tube placement, and pericardiocentesis. Sixteen days after admission, a chest MRI (magnetic resonance imaging) revealed a large infiltrative mass of the superior mediastinum, consistent with kaposiform hemangioendothelioma (KHE). The patient's thrombocytopenia was due to associated Kasabach-Merritt phenomenon (KMP). The patient now has complete resolution of KMP after medical treatment with prednisolone, aminocaproic acid, vincristine, and aspirin.
引用
收藏
页码:563 / 567
页数:5
相关论文
共 50 条
  • [1] Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon
    Pati, Sananda
    Das, Mrinal Kanti
    Rana, Akshay
    Das, Emilee
    Sarkar, Soumyadeep
    Sherpa, Norbu
    Datta, Supratim
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2021, 88 (11): : 1142 - 1144
  • [2] Abdominal kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon
    Lee, E
    Mousdicas, N
    Roumpf, S
    Billings, S
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB177 - AB177
  • [4] Mediastinal Kaposiform Hemangioendothelioma and Kasabach-Merritt Phenomenon in an Infant Treatment With Interferon
    Hartman, Kip R.
    Moncur, Joel T.
    Minniti, Caterina P.
    Creamer, Kevin M.
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (09) : 690 - 692
  • [5] Kaposiform hemangioendothelioma with associated Kasabach-Merritt phenomenon
    Arnaout, MK
    Pappo, AS
    [J]. JOURNAL OF PEDIATRICS, 1998, 133 (06): : 788 - 788
  • [6] Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon
    Gruman, A
    Liang, MG
    Mulliken, JB
    Fishman, SJ
    Burrows, PE
    Kozakewich, HPW
    Blei, F
    Frieden, IJ
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (04) : 616 - 622
  • [7] Sirolimus for Kaposiform Hemangioendothelioma and Kasabach-Merritt Phenomenon in a Neonate
    Cabrera, Trevor B.
    Speer, Allison L.
    Greives, Matthew R.
    Goff, Donna A.
    Menon, Neethu M.
    Reynolds, Eric W.
    [J]. AJP REPORTS, 2020, 10 (04): : E390 - E394
  • [8] Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants
    Wang, Yuan
    Kong, Liangliang
    Sun, Buhao
    Cui, Jie
    Shen, Weimin
    [J]. JOURNAL OF CRANIOFACIAL SURGERY, 2020, 31 (04) : 1074 - 1077
  • [9] Kaposiform hemangioendothelioma with fatal income: Kasabach-Merritt phenomenon and hypercalcemia
    Massara, Baklouti
    Mariem, Rekik
    Emna, Bahloul
    Meriam, Triki
    Faiza, Safi
    Sonia, Boudaya
    Meriem, Amouri
    Lamia, Gargouri
    Tahia, Sellami
    Hamida, Turki
    [J]. CLINICAL CASE REPORTS, 2022, 10 (02):
  • [10] Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon: From Vincristine to Sirolimus
    Jahnel, J.
    Lackner, H.
    Reiterer, F.
    Urlesberger, B.
    Urban, C.
    [J]. KLINISCHE PADIATRIE, 2012, 224 (06): : 395 - 397